MedEye Associates - Miami — South Miami, Florida

MedEye Associates - Miami is a clinical research site located in South Miami, Florida, United States 33143.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

MedEye Associates - Miami has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Neovascular Age-Related Macular Degeneration.

Sponsors: Ocular Therapeutix, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in South Miami

Browse all research sites in Florida · View every site in South Miami

• Miami Children's Hospital
• University of Miami
• South Miami Hospital
• Larkin Hospital
• Larkin Community Hospital
• Westchester General Hospital
• Baptist Health South Florida/South Miami Hospital
• Miami Research Associates
• Qps-Mra Llc
• Pfizer Investigational Site
• Research Site
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MedEye Associates - Miami?

MedEye Associates - Miami has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MedEye Associates - Miami conducted?

MedEye Associates - Miami has 1 clinical trials on record, with 1 currently active. Their work covers Neovascular Age-Related Macular Degeneration.

Is MedEye Associates - Miami accredited by Crixeo Clinical Trials?

MedEye Associates - Miami has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MedEye Associates - Miami?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.